Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Borrego, Jesús; Feher, Adam; Jost, Norbert; Panyi, Gyorgy; Varga, Zoltan; Papp, Ferenc.

Afiliación

Borrego J; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem ter 1, H-4032 Debrecen, Hungary.
Feher A; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem ter 1, H-4032 Debrecen, Hungary.
Jost N; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Szeged, 6725 Szeged, Hungary.
Panyi G; Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, University of Szeged, 6725 Szeged, Hungary.
Varga Z; ELKH-SZTE Research Group for Cardiovascular Pharmacology, Eötvös Loránd Research Network, 6725 Szeged, Hungary.
Papp F; Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem ter 1, H-4032 Debrecen, Hungary.

Pharmaceuticals (Basel) ; 14(12)2021 Dec 14.

Article en En | MEDLINE | ID: mdl-34959701